Disc Medicine (IRON) Other Accumulated Expenses (2020 - 2026)

Disc Medicine (IRON) reported Other Accumulated Expenses of $870000.0 for Q1 2026, up 71.6% year-over-year from $507000.0 in Q1 2025, and up 23.4% quarter-over-quarter from $705000.0 in Q4 2025.

Disc Medicine (IRON) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

Disc Medicine (IRON) has 7 years of Other Accumulated Expenses data on file, last reported at $870000.0 in Q1 2026.

  • Other Accumulated Expenses for Q1 2026 came in at $870000.0, up 71.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $870000.0 (up 71.6% YoY), and the FY2025 annual result was $705000.0, up 98.59% from the prior year.
  • Other Accumulated Expenses climbed to $870000.0 in Q1 2026 per IRON's latest filing, from $705000.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $870000.0 in Q1 2026 and troughed at $52000.0 in Q4 2023.
  • A 5-year average of $390428.6 and a median of $291000.0 in 2023 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses surged 880.95% in 2022, then sank 74.76% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $206000.0 in 2022, then slumped by 74.76% to $52000.0 in 2023, then surged by 582.69% to $355000.0 in 2024, then surged by 98.59% to $705000.0 in 2025, then advanced by 23.4% to $870000.0 in 2026.
  • Business Quant data shows IRON's Other Accumulated Expenses at $870000.0 in Q1 2026, $705000.0 in Q4 2025, and $749000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Disc Medicine 2.62 Bn 1.89 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 870,000.00
Dec 31, 2025 705,000.00
Sep 30, 2025 749,000.00
Jun 30, 2025 810,000.00
Mar 31, 2025 507,000.00
Dec 31, 2024 355,000.00
Sep 30, 2024 237,000.00
Jun 30, 2024 188,000.00
Mar 31, 2024 199,000.00
Dec 31, 2023 52,000.00
Sep 30, 2023 54,000.00
Jun 30, 2023 189,000.00
Mar 31, 2023 345,000.00
Dec 31, 2022 206,000.00
Dec 31, 2021 21,000.00
Sep 30, 2021 16,000.00
Jun 30, 2021 147,000.00
Mar 31, 2021 87,000.00
Dec 31, 2020 46,000.00